Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Pre-clinical evaluation of a replication-competent recombinant adenovirus serotype 4 vaccine expressing influenza H5 hemagglutinin.

Alexander J, Ward S, Mendy J, Manayani DJ, Farness P, Avanzini JB, Guenther B, Garduno F, Jow L, Snarsky V, Ishioka G, Dong X, Vang L, Newman MJ, Mayall T.

PLoS One. 2012;7(2):e31177. doi: 10.1371/journal.pone.0031177. Epub 2012 Feb 17.

2.

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis.

Osterholm MT, Kelley NS, Sommer A, Belongia EA.

Lancet Infect Dis. 2012 Jan;12(1):36-44. doi: 10.1016/S1473-3099(11)70295-X. Epub 2011 Oct 25. Review. Erratum in: Lancet Infect Dis. 2012 Sep;12(9):655.

PMID:
22032844
3.

Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children.

Black S, Nicolay U, Vesikari T, Knuf M, Del Giudice G, Della Cioppa G, Tsai T, Clemens R, Rappuoli R.

Pediatr Infect Dis J. 2011 Dec;30(12):1081-5. doi: 10.1097/INF.0b013e3182367662. Erratum in: Pediatr Infect Dis J. 2012 May;31(5):537.

PMID:
21983214
4.

DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials.

Ledgerwood JE, Wei CJ, Hu Z, Gordon IJ, Enama ME, Hendel CS, McTamney PM, Pearce MB, Yassine HM, Boyington JC, Bailer R, Tumpey TM, Koup RA, Mascola JR, Nabel GJ, Graham BS; VRC 306 Study Team.

Lancet Infect Dis. 2011 Dec;11(12):916-24. doi: 10.1016/S1473-3099(11)70240-7. Epub 2011 Oct 3.

PMID:
21975270
5.

Two is better than one.

Lu S.

Lancet Infect Dis. 2011 Dec;11(12):889-91. doi: 10.1016/S1473-3099(11)70256-0. Epub 2011 Oct 3. No abstract available.

PMID:
21975267
6.

Phase 1 study of the safety and immunogenicity of a live, attenuated respiratory syncytial virus and parainfluenza virus type 3 vaccine in seronegative children.

Bernstein DI, Malkin E, Abughali N, Falloon J, Yi T, Dubovsky F; MI-CP149 Investigators.

Pediatr Infect Dis J. 2012 Feb;31(2):109-14. doi: 10.1097/INF.0b013e31823386f1.

PMID:
21926667
7.

Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine.

Chirkova TV, Naykhin AN, Petukhova GD, Korenkov DA, Donina SA, Mironov AN, Rudenko LG.

Clin Vaccine Immunol. 2011 Oct;18(10):1710-8. doi: 10.1128/CVI.05116-11. Epub 2011 Aug 3.

8.

Rapid immunization against H5N1: a randomized trial evaluating homologous and cross-reactive immune responses to AS03(A)-adjuvanted vaccination in adults.

Lasko B, Reich D, Madan A, Roman F, Li P, Vaughn D.

J Infect Dis. 2011 Aug 15;204(4):574-81. doi: 10.1093/infdis/jir328.

9.

Combined, concurrent, and sequential administration of seasonal influenza and MF59-adjuvanted A/H5N1 vaccines: a phase II randomized, controlled trial of immunogenicity and safety in healthy adults.

Lopez P, Caicedo Y, Sierra A, Tilman S, Banzhoff A, Clemens R.

J Infect Dis. 2011 Jun 15;203(12):1719-28. doi: 10.1093/infdis/jir191.

PMID:
21606530
10.

An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults.

Talaat KR, Karron RA, Luke CJ, Thumar B, McMahon BA, Chen GL, Lamirande EW, Jin H, Coelingh KL, Kemble G, Subbarao K.

Vaccine. 2011 Apr 12;29(17):3144-8. doi: 10.1016/j.vaccine.2011.02.043. Epub 2011 Mar 4.

11.

Progress in filovirus vaccine development: evaluating the potential for clinical use.

Falzarano D, Geisbert TW, Feldmann H.

Expert Rev Vaccines. 2011 Jan;10(1):63-77. doi: 10.1586/erv.10.152. Review.

12.

Novel adenovirus vector-based vaccines for HIV-1.

Barouch DH.

Curr Opin HIV AIDS. 2010 Sep;5(5):386-90. doi: 10.1097/COH.0b013e32833cfe4c. Review.

13.

Replicating viral vectors as HIV vaccines: summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference.

Excler JL, Parks CL, Ackland J, Rees H, Gust ID, Koff WC.

Biologicals. 2010 Jul;38(4):511-21. doi: 10.1016/j.biologicals.2010.03.005.

PMID:
20537552
14.

Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus.

McCullers JA, Van De Velde LA, Allison KJ, Branum KC, Webby RJ, Flynn PM.

Clin Infect Dis. 2010 Jun 1;50(11):1487-92. doi: 10.1086/652441.

15.

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH; MOPH-TAVEG Investigators.

N Engl J Med. 2009 Dec 3;361(23):2209-20. doi: 10.1056/NEJMoa0908492. Epub 2009 Oct 20.

16.

Recombinant vectors as influenza vaccines.

Kopecky-Bromberg SA, Palese P.

Curr Top Microbiol Immunol. 2009;333:243-67. doi: 10.1007/978-3-540-92165-3_13. Review.

PMID:
19768410
17.

Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.

Karron RA, Talaat K, Luke C, Callahan K, Thumar B, Dilorenzo S, McAuliffe J, Schappell E, Suguitan A, Mills K, Chen G, Lamirande E, Coelingh K, Jin H, Murphy BR, Kemble G, Subbarao K.

Vaccine. 2009 Aug 6;27(36):4953-60. doi: 10.1016/j.vaccine.2009.05.099. Epub 2009 Jun 21.

18.

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.

Talaat KR, Karron RA, Callahan KA, Luke CJ, DiLorenzo SC, Chen GL, Lamirande EW, Jin H, Coelingh KL, Murphy BR, Kemble G, Subbarao K.

Vaccine. 2009 Jun 8;27(28):3744-53. doi: 10.1016/j.vaccine.2009.03.082. Epub 2009 Apr 17.

19.

Delivery of human immunodeficiency virus vaccine vectors to the intestine induces enhanced mucosal cellular immunity.

Wang L, Cheng C, Ko SY, Kong WP, Kanekiyo M, Einfeld D, Schwartz RM, King CR, Gall JG, Nabel GJ.

J Virol. 2009 Jul;83(14):7166-75. doi: 10.1128/JVI.00374-09. Epub 2009 May 6.

20.

A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults.

Karron RA, Callahan K, Luke C, Thumar B, McAuliffe J, Schappell E, Joseph T, Coelingh K, Jin H, Kemble G, Murphy BR, Subbarao K.

J Infect Dis. 2009 Mar 1;199(5):711-6. doi: 10.1086/596558.

Supplemental Content

Support Center